Cologuard
Selected indexed studies
- Multitarget Stool DNA Testing (Cologuard) for Colorectal Cancer Screening. (Am Fam Physician, 2022) [PMID:35166507]
- Cologuard test: A Possible Alternate To Colonoscopy? (J Ayub Med Coll Abbottabad, 2017) [PMID:28712205]
- Cologuard Plus - an at-home stool DNA test for colorectal cancer screening. (Med Lett Drugs Ther, 2025) [PMID:40324962]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Multitarget Stool DNA Testing (Cologuard) for Colorectal Cancer Screening. (2022) pubmed
- Cologuard test: A Possible Alternate To Colonoscopy? (2017) pubmed
- Cologuard Plus - an at-home stool DNA test for colorectal cancer screening. (2025) pubmed
- Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort study. (2023) pubmed
- Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy. (2024) pubmed
- From Detection to Delay: Real-World Gaps in Post-Cologuard(®) Colonoscopy Adherence. (2025) pubmed
- Positive Fecal Immunochemical Test or Cologuard in the Era of the Novel Coronavirus Disease-2019 Pandemic. (2020) pubmed
- Cost-effectiveness of Novel Noninvasive Screening Tests for Colorectal Neoplasia. (2025) pubmed
- Colorectal cancer screening. (2019) pubmed
- Improving colorectal cancer screening through Cologuard education: a quality improvement initiative in an urban primary care clinic. (2025) pubmed